Although questions are starting to pop up over a number of health care industries, the medical device segment continues to be a strong performer. This area, which includes companies that are focused on a variety of medical products such as stents, catheters and the like, tends to be more stable than many of the drug businesses, though still a vital part of the overall health care industry.
The sector has also been able to navigate the recent health care sector changes with ease and it has maintained a nice history of outperformance. We can see this by looking at Medtronic (MDT - Free Report) which also seen a nice run over the past two years. However, as we note in the chart below, the performance has really just been in-line with the industry at large.
While this was fine for a while, MDT will have to deliver the goods eventually. And with an incredible run to start 2016, this quarter could be a very important one for Medtronic.
This is especially true given the recent estimate trend for MDT shares. Coming into the report earnings estimates have been declining a little bit, and the stock actually was just downgraded into ‘hold’ territory too.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Although questions are starting to pop up over a number of health care industries, the medical device segment continues to be a strong performer. This area, which includes companies that are focused on a variety of medical products such as stents, catheters and the like, tends to be more stable than many of the drug businesses, though still a vital part of the overall health care industry.
The sector has also been able to navigate the recent health care sector changes with ease and it has maintained a nice history of outperformance. We can see this by looking at Medtronic (MDT - Free Report) which also seen a nice run over the past two years. However, as we note in the chart below, the performance has really just been in-line with the industry at large.
While this was fine for a while, MDT will have to deliver the goods eventually. And with an incredible run to start 2016, this quarter could be a very important one for Medtronic.
This is especially true given the recent estimate trend for MDT shares. Coming into the report earnings estimates have been declining a little bit, and the stock actually was just downgraded into ‘hold’ territory too.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MDT - FREE
Get the latest research report on IHI - FREE